The pH-selective anti-VISTA antibody SNS-101 displays a favorable pharmacokinetic and safety profile and promotes anti-tumoral M1 macrophage polarization in PD-1 refractory settings
Thisted, T., Smith, F.D., Zhang, G., Feng, F., Kleschenko, Y., Mukherjee, A., Jiang, Z., Malhotra, K., Biesova, Z., Onumajuru, A., Gaelle, M., Takeuchi, Y., Thiam, K., Schreiber, R.D., van der Horst, E.H.To be published.